Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

58.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.9K
What is Genetic Engineering?00:49

What is Genetic Engineering?

81.2K
Overview
81.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moving from subjectivity to standardization? The emerging role of artificial intelligence in the embryology laboratory.

F&S reports·2026
Same author

Maturation takes time: long-term follow-up after capacitation in-vitro maturation.

Fertility and sterility·2026
Same author

Asymmetric attrition and secondary chromosome destabilization after double-strand breaks in human embryonic development.

Nature communications·2026
Same author

Recurrent assisted reproductive technology failure: the embryo perspective.

Fertility and sterility·2026
Same author

An advanced SWOT analysis of elective vitrification: today's standard IVF procedure.

Reproductive biomedicine online·2026
Same author

Platelet-rich plasma for ovarian "rejuvenation": evidence lagging, safety missing.

F&S reports·2026

Related Experiment Video

Updated: Mar 23, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.6K

Challenges facing contemporary preimplantation genetic screening.

Caroline Juneau1, Jason Franasiak, Nathan Treff

  • 1aReproductive Medicine Associates of New Jersey, Basking Ridge bRutgers, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Current Opinion in Obstetrics & Gynecology
|April 5, 2016
PubMed
Summary
This summary is machine-generated.

Preimplantation genetic screening (PGS) improves pregnancy rates, but some euploid embryos still fail to implant. Further research is needed to understand the impact of mosaicism and segmental aneuploidy on implantation success.

More Related Videos

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

10.0K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K

Related Experiment Videos

Last Updated: Mar 23, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.6K
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

10.0K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K

Area of Science:

  • Reproductive Medicine
  • Genetics
  • Embryology

Background:

  • Aneuploidy is a primary cause of pregnancy loss.
  • Preimplantation genetic screening (PGS) has evolved with validated techniques improving pregnancy rates.
  • Despite advancements, many chromosomally normal (euploid) embryos fail to implant, necessitating further investigation.

Purpose of the Study:

  • To review current understanding of preimplantation genetic screening (PGS).
  • To explore reasons for euploid embryo implantation failure.
  • To highlight the ongoing investigation into mosaicism and segmental aneuploidy.

Main Methods:

  • Review of Class I data on trophectoderm biopsy safety and accuracy of aneuploidy detection methods (SNP array, qPCR, NGS).
  • Analysis of randomized control trials (RCTs) on PGS clinical utility.
  • Examination of recent data concerning mosaicism and segmental aneuploidy.

Main Results:

  • Trophectoderm biopsy is safe; SNP array and qPCR accurately detect whole chromosome aneuploidy.
  • RCTs demonstrate the clinical utility of PGS in improving implantation rates.
  • The clinical relevance and detection accuracy of mosaicism and segmental aneuploidy require further clarification.

Conclusions:

  • While PGS improves implantation rates, euploid failures suggest undetected mosaicism or segmental aneuploidy.
  • The precise incidence, dispersion, and detection resolution of mosaicism remain unclear.
  • Further research and Class I data are essential to validate detection algorithms and assess their impact on outcomes.